242 related articles for article (PubMed ID: 7043017)
1. Effects of norepinephrine infusion on systemic hemodynamics and plasma 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension.
Ishii M; Uehara Y; Hirata Y; Atarashi K; Ikeda T; Sugimoto T; Takeda T; Murao S
Jpn Circ J; 1982 May; 46(5):494-502. PubMed ID: 7043017
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension.
Uehara Y; Ishii M; Ikeda T; Atarashi K; Takeda T; Murao S
Prostaglandins Leukot Med; 1983 Apr; 10(4):455-64. PubMed ID: 6344103
[TBL] [Abstract][Full Text] [Related]
3. Effects of high salt intake on hemodynamic responses to isometric exercise in normotensive subjects and in patients with essential hypertension.
Ishii M; Sugimoto T; Atarashi K; Igari T; Uehara Y; Doi M; Takagi M; Matsuoka H; Ikeda T; Murao S
Jpn Circ J; 1983 Oct; 47(10):1248-54. PubMed ID: 6355552
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension.
Uehara Y; Ishii M; Ikeda T; Atarashi K; Takeda T; Murao S
Prostaglandins Leukot Med; 1983 May; 11(1):95-104. PubMed ID: 6348803
[TBL] [Abstract][Full Text] [Related]
5. Effects of prostacyclin infusion on blood pressure and plasma renin activity in patients with essential hypertension.
Kato T; Yoneda S; Koketsu M; Fujinami T
Angiology; 1992 Feb; 43(2):110-20. PubMed ID: 1536471
[TBL] [Abstract][Full Text] [Related]
6. Abnormal response of urinary eicosanoid system to norepinephrine infusion in patients with essential hypertension.
Uehara Y; Ishimitsu T; Kawabata Y; Matsuoka H; Ishii M; Sugimoto T
Prostaglandins Leukot Essent Fatty Acids; 1992 Jun; 46(2):99-104. PubMed ID: 1502257
[TBL] [Abstract][Full Text] [Related]
7. Eicosanoid modulation of the norepinephrine effect on blood pressure and renal hemodynamics in humans.
Isenring P; Lebel M; Falardeau P; Grose JH
Prostaglandins Leukot Essent Fatty Acids; 1996 Jan; 54(1):59-63. PubMed ID: 8992495
[TBL] [Abstract][Full Text] [Related]
8. Effect of aging on 6-keto-PGF1 alpha levels in normotensive and essential hypertensive males.
Gotoh S; Ogihara T; Nakamaru M; Masuo K; Hata T; Kumahara Y
Jpn Circ J; 1983 Mar; 47(3):309-12. PubMed ID: 6687615
[TBL] [Abstract][Full Text] [Related]
9. Levels of plasma 6-keto-PGF1 alpha in normotensive and essential hypertensive males with and without a family history of hypertension.
Gotoh S; Ogihara T; Nakamaru M; Masuo K; Hata T; Kumahara Y
Prostaglandins Leukot Med; 1983 Jan; 10(1):27-32. PubMed ID: 6572404
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of 6-keto-prostaglandin F1 alpha, thromboxane B2 and platelet aggregation in patients with essential hypertension.
Chen LS; Ito T; Ogawa K; Shikano M; Satake T
Jpn Heart J; 1984 Nov; 25(6):1001-9. PubMed ID: 6549401
[TBL] [Abstract][Full Text] [Related]
11. Measurement of 6-keto-prostaglandin E1 alpha in human plasma with radioimmunoassay: effect of prostacyclin infusion.
Ylikorkala D; Viinikka L
Prostaglandins Med; 1981 Apr; 6(4):427-36. PubMed ID: 7025068
[TBL] [Abstract][Full Text] [Related]
12. Evidence that prostacyclin modulates the vascular actions of calcium in man.
Nadler JL; McKay M; Campese V; Vrbanac J; Horton R
J Clin Invest; 1986 Apr; 77(4):1278-84. PubMed ID: 3514678
[TBL] [Abstract][Full Text] [Related]
13. Renal eicosanoids and renal hemodynamics in early borderline hypertension.
Lebel M; Grose JH
Clin Invest Med; 1991 Dec; 14(6):525-34. PubMed ID: 1794206
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
Firth BG; Winniford MD; Campbell WB; Hillis LD
Am J Cardiol; 1983 Sep; 52(5):439-43. PubMed ID: 6351580
[TBL] [Abstract][Full Text] [Related]
15. Release of prostaglandins by the mesenteric artery of the renovascular and spontaneously hypertensive rat.
Desjardins-Giasson S; Gutkowska J; Garcia R; Genest J
Can J Physiol Pharmacol; 1984 Jan; 62(1):89-93. PubMed ID: 6546893
[TBL] [Abstract][Full Text] [Related]
16. Ibuprofen pretreatment inhibits prostacyclin release during abdominal exploration in aortic surgery.
Hudson JC; Wurm WH; O'Donnel TF; Kane FR; Mackey WC; Su YF; Watkins WD
Anesthesiology; 1990 Mar; 72(3):443-9. PubMed ID: 2106806
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol.
Roy L; Mehta J; Mehta P
Am J Cardiol; 1983 Feb; 51(3):464-7. PubMed ID: 6823861
[TBL] [Abstract][Full Text] [Related]
18. Rapid and effective conversion of 6-keto-prostaglandin F1 alpha to 6,15-diketo-13, 14-dihydro-prostaglandin F1 alpha-immunoreactive material in vivo.
Förstermann U; Neufang B; Hertting G
Prostaglandins Leukot Med; 1982 Sep; 9(3):277-84. PubMed ID: 6752956
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin in (extracted) plasma of essential hypertensives.
Sundar S
Acta Cardiol; 1987; 42(2):135-9. PubMed ID: 3300116
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
